HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Acetohydroxamic Acid

HCID 1990
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
546-88-3
Standard SMILES
CC(=O)NO
InChIKey
RRUDCFGSUDOHDG-UHFFFAOYSA-N
Molecular formula
C2H5NO2
Average molar mass
75.07 g/mol
Monoisotopic mass
75.0320284

Overview

Acetohydroxamic Acid can cause developmental toxicity according to state or federal government labeling requirements.

Names & identifiers

Preferred name
Acetohydroxamic Acid
IUPAC
N-hydroxyacetamide
English name
Acetohydroxamic acid
Molecular formula
C2H5NO2
Molecular weight
75.07

Names & synonyms

acetohydroxamic acidN-Hydroxyacetamide546-88-3Acetylhydroxamic acidLithostatAcetic acid, oximeMethylhydroxamic acidAcetohydroximic acidN-AcetylhydroxylamineAcethydroxamsaeurecetohyroxamic acidN-Acetyl hydroxyacetamide
Show more names
AHAAcetylhydroxylamineAcetomenadioneN-hydroxyacetimidic acidT-41BNSC 5073yangwosuan
Acido acetohidroxamicoAcide acetohydroxamiqueAcidum acetohydroxamicumn-hydroxy-acetamideDTXSID7022546NSC-1761364RZ82L2GY5DTXCID802546

Database identifiers

CAS
546-88-3
PubChem CID
1990
DTXSID
DTXSID7022546
ChEMBL
CHEMBL734
ChEBI
CHEBI:27777
UNII
4RZ82L2GY5
EC Number
208-913-8
Nikkaji
J23.285H

Properties

Computed structural properties

XLogP
-1.6
Topological polar surface area
49.3 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
2
Rotatable bonds
0
Heavy atoms
5
Formal charge
0
Complexity
42.9

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
pH9.39 (aq soln)
SpringerMaterials PropertiesChemical shift
LogP · 3 items

log Kow= -1.59

-0.7

-1.59

Solubility · 2 items

5.09e+02 g/L

<0.2 [ug/mL] (The mean of the results at pH 7.4)

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

DecompositionWhen heated to decomposition it emits toxic fumes of nitroxides.
Melting Point · 2 items

89-92 °C

90.5 °C

Physical DescriptionSolid
Dissociation Constants

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H360 (96.1%): May damage fertility or the unborn child [Danger Reproductive toxicity]

P203, P280, P318, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 51 reports by companies from 9 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory InformationHazard Traits - Developmental Toxicity
FDA Requirements · 1 item

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Hazard Classes and CategoriesRepr. 1B (96.1%)

Safety & protection

Disposal Methods · 1 item

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Toxicology

Interactions · 3 items

Concurrent use of alcoholic beverages with acetohydroxamic acid has resulted in a nonpruritic, reddish, macular skin rash about 30 to 45 minutes after ingestion. The rash may be associated with a general feeling of warmth and tingling, and usually disappears spontaneously in 30 to 60 minutes.

Chemistry & industry

Pharmacology

ATC Code · 2 items

G - Genito urinary system and sex hormones

QG - Genito urinary system and sex hormones

Protein BindingNo known binding
Pharmacodynamics · 1 item

Acetohydroxamic Acid, a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea. In the urine, it acts as an antagonist of the bacterial enzyme urease. Acetohydroxamic Acid has no direct antimicrobial action and does not acidify urine directly.

Mechanism of Action · 2 items

Acetohydroxamic Acid reversibly inhibits the bacterial enzyme urease. This inhibits the hydrolysis of urea and production of ammonia in urine infected with urea-splitting organisms, leading to a decrease in pH and ammonia levels. As antimicrobial agents are more effective in such conditions, the effectiveness of these agents is amplified, resulting in a higher cure rate.

Inhibits the hydrolysis of urea and production of ammonia in urine infected with urea-splitting bacteria, by reversible inhibition of the bacterial enzyme urease, and by the chelation of nickel, an essential component of urease enzymes. Such enzyme inhibition results in reduction of both urine alkalinity and ammonia concentration. The effectiveness of antibacterial medication is then enhanced and the formation of urinary calculi reduced.

Biological Half-Life · 2 items

5-10 hours in patients with normal renal function

...increases with increasing dose and reportedly ranges from about 3.5-10 hours in patients with normal renal function.

Metabolism/Metabolites · 2 items

35-65% of oral dose excreted unchanged in urine (which provides the drug's therapeutic effect).

...is metabolized to acetamide.

FDA Pharmacological Classification · 6 items

4RZ82L2GY5

ACETOHYDROXAMIC ACID

Established Pharmacologic Class [EPC] - Urease Inhibitor

Related reactions

55 records
New reaction record
HRID 16396 reaction equation
HRID 16396As reactant
HRID 82191 reaction equation
HRID 82191As reactant
HRID 82777 reaction equation
HRID 82777As reactant
HRID 241954 reaction equation
HRID 241954As reactant
HRID 243823 reaction equation
HRID 243823As reactant
HRID 245354 reaction equation
HRID 245354As reactant
HRID 423274 reaction equation
HRID 423274As reactant
HRID 475021 reaction equation
HRID 475021As reactant
PreviousPage 1 of 7

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
· 2 items

8.7 (at 25 °C)

pKa= 8.70

Physicochemical properties

Melting point
88 · 88-90 °C (lit.)
Boiling point
133.7 °C · 133.7°C (rough estimate)
Density
1.2269 · 1.2269 (rough estimate)
refractive index
1.4264 · 1.4264 (estimate)
storage temp.
Keep in dark place,Inert atmosphere,Room temperature
solubility
Methanol (Sparingly), Water (Sparingly)
form
Crystalline Solid
pka
8.7 · 8.70(at 25℃)
color
White to pale yellow
Water Solubility
Soluble in water.
Sensitive
Hygroscopic
Merck
14 · 14,63
BRN
1739019 · 1739019
Stability
Moisture and Temperature Sensitive
InChI
1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)
InChIKey
RRUDCFGSUDOHDG-UHFFFAOYSA-N
SMILES
CC(NO)=O
CAS DataBase Reference
546 · 546-88-3(CAS DataBase Reference)
EWG's Food Scores
2 · 2
NCI Dictionary of Cancer Terms
AHA
FDA UNII
4 RZ82L2GY5 · 4RZ82L2GY5
ATC code
4 BX03 · G04BX03
Proposition 65 List
Acetohydroxamic Acid
NIST Chemistry Reference
Acetamide,N-hydroxy(546-88-3)
EPA Substance Registry System
Acetohydroxamic acid (546-88-3)
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
8 · GHS08
Signal word
Danger
Hazard statements
360 · H360
Precautionary statements
201 · P201-P280-P308+P313
PPE
2 · Eyeshields, Gloves, type P2 (EN 143) respirator cartridges
Hazard Codes
T
Risk Statements
61 · 61-40
Safety Statements
53 · 53-45-36/37/39-22
RIDADR
3263 · 3263
WGK Germany
3 · 3
RTECS
8157000 · AK8157000
Hazard Note
Toxic
PackingGroup
II
HS Code
2928000090 · 2928000090
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
1 B · Repr. 1B
Hazardous Substances Data
546 · 546-88-3(Hazardous Substances Data)
Toxicity
160 mmol/plate · mmo-sat 160 mmol/plate JOPHDQ 3,557,80

Acetohydroxamic acid chelates iron and possibly other heavy metals with concurrent oral administration; this may result in reduced intestinal absorption of both; if iron therapy is indicated, parenteral administration of iron is recommended.

In vitro studies indicate that acetohydroxamic acid and methenamine have a synergistic effect in inhibiting increases in pH caused by urease-producing Proteus spp. and that acetohydroxamic acid potentiates the antibacterial effect of methenamine against these bacteria...

Human Toxicity Excerpts · 2 items

Acetohydroxamic acid was positive for mutagenicity in the Ames test.

Acetohydroxamic acid overdose has not been reported. However, if it should occur, concomitant reduction in platelets and/or white blood cells should be anticipated; reticulocyte count is likely to be elevated, and severe hemolysis may occur.

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Acetohydroxamic acid

Ambiguous-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Non-Human Toxicity Excerpts · 3 items

Acetamide, a metabolite or acetohydroxamic acid, has been shown to cause hepatocellular carcinoma in rats when used in very high doses.

...in long-term studies in rats, large oral dosages (e.g., 4 g/kg daily) of acetamide, a metabolite of acetohydroxamic acid, have been shown to cause hepatocellular carcinoma.

Evidence of toxicity did not occur when the drug was administered subcutaneously in mice at a dosage of 500 mg/kg daily for 60-100 days; however, evidence of cumulative toxicity, with death occurring at a mean of 21 days, occurred when the drug was administered subcutaneously at a dosage of 1 g/kg daily.

Antidote and Emergency Treatment · 1 item

Treatment of overdose: Administration should be stopped. There is no known specific antidote for acetohydroxamic acid overdose. Recommended treatment consists of the following: Monitoring - Close monitoring of hematologic status; Specific Treatment - Symptomatic treatment as necessary. Blood transfusions if required. Dialysis (considered possible but not yet proven).

Non-Human Toxicity Values · 3 items

LD50 Mouse ip 2.5 g/kg

LD50 Mouse oral 5 g/kg

LD50 Rat oral 4.8 g/kg

Regulatory information

FDA Requirements · 1 item

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Safety data

PPE
Eyeshields, Gloves, type P2 (EN 143) respirator cartridges
wgk
3
rtecs
AK8157000
ridadr
3263
hs_code
2928000090
Toxicity
mmo-sat 160 mmol/plate JOPHDQ 3,557,80
risk_code
61-40
Signal word
Danger
Symbol(GHS)
GHS08
hazard_code
T
hazard_note
Toxic
safety_code
53-45-36/37/39-22
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
II
Hazard statements
H360
Hazard Classifications
Repr. 1B
Precautionary statements
P201-P280-P308+P313
Hazardous Substances Data
546-88-3(Hazardous Substances Data)

Mechanisms of Action [MoA] - Urease Inhibitors

Acetohydroxamic acid is an Urease Inhibitor. The mechanism of action of acetohydroxamic acid is as an Urease Inhibitor.

ACETOHYDROXAMIC ACID

MeSH Pharmacological ClassificationCompounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Absorption, Distribution and Excretion · 6 items

Well absorbed from the GI tract following oral administration.

Well absorbed from gastrointestinal tract.

Well distributed throughout body fluids.

Elimination: Renal- Unchanged, 36 to 65%; as acetamide, 9 to 14%. Respiratory - As carbon dioxide, 20 to 40%.

In rodents, about 55% of an intraperitoneal dose is excreted in urine as unchanged drug, 15% as acetamide, and 10% as acetate within 24 hours; approximately 7% of the dose is excreted by the lungs as carbon dioxide and less than 1% is excreted in feces within 24 hours.

In mice, highest concentrations of the drug occur in the liver and kidney, while the lowest concentrations occur in the brain.

Cellular LocationsCytoplasm

Uses & manufacturing

UsesMEDICATION
Applications · 5 items

DescriptionAcetohydroxamic acid is a potent, non-competitive and irreversible inhibitor of bacterial urease (Ki≈lO-7M). This enzyme, which is widely distributed in plants and bacteria, but not in mammalian cells, catalyzes the decomposition of urea to ammonia. Elevated urinary ammonia levels can reduce the antibacterial effectiveness of a number of agents. Thus, acetohydroxamic acid is useful as adjunctive therapy to decrease urinary ammonia and alkalinity in patients with chronic urea-splitting urinary infection. Such infections are a leading cause of recurring complications and death in paraplegics.

UsesAcetohydroxamic acid is a potent inhibitor of bacterial urease activity and reduces urinary ammonia levels. 2-Acetohydroxamic acid loaded floating microspheres forms an efficient drug delivery system for the treatment of Helicobacter pylori.Acetohydroxamic acid was used:to study the mechanism of complexation of iron (III) with acetohydroxamic acid.to study the inhibitory mechanism of lansoprazole and omeprazole on Helicobacter pyloni.in urease inhibition studies.for in situ generation of nitrosocarbonylmethane as a Diels-Alder dienophile.Used in urease inhibition studies and for in situ generation of nitrosocarbonylmethane as a Diels-Alder dienophile.

UsesA urease inhibitor. Used in the synthesis

UsesUrease inhibitorAcetohydroxamic acid acts as a drug, as an inhibitor of bacterial and plant urease, which is used for urinary tract infections. It is also used in organic synthesis. It acts as an antiurolithic and antibacterial agent. It is involved in the study of complexation of iron(III) with acetohydroxamic acid as well as in the inhibition study of lansoprazole and omeprazole on Helicobacter pyloni. It plays an important role in the insitu generation of nitrosocarbonylmethane as a Diels-Alder dienophile. In addition to this, it is used in the treatment of kidney stones and urinary tract infections.

General DescriptionAcetohydroxamic acid is a potent inhibitor of bacterial urease activity and reduces urinary ammonia levels. 2-Acetohydroxamic acid loaded floating microspheres forms an efficient drug delivery system for the treatment of Helicobacter pylori.

Upstream & downstream products

Upstream raw materials

Hydroxylamine

Downstream products

AcetaldoximeCaracemide5-(trifluoromethyl)benzo[d]isoxazol-3-amine
Additional notes · 1 item

DefinitionChEBI: Acetohydroxamic acid is a member of the class of acetohydroxamic acids that is acetamide in which one of the amino hydrogens has been replaced by a hydroxy group. It has a role as an EC 3.5.1.5 (urease) inhibitor and an algal metabolite. It is functionally related to an acetamide. It is a tautomer of a N-hydroxyacetimidic acid.